S. Del Signore and R.Roubenff

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

We agree with regulators that better characterization of subpopulations, not only in elderly patients, can improve the benefit risk ratio of medicines. At the same time, we believe it is in the public health interest to develop novel drugs indicated for specific geriatric conditions.

M. Vollenbroek-Hutten, S. Jansen-Kosterink, M. Tabak, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

Aim of this article is to describe the possible field of application for ICTsupported services in the management of older adults, in particular those with functional impairment.

M. Cesari, E. Marzetti, R. Calvani, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

The lack of consensus around a single operational definition has limited the clinical implementation of frailty in clinical practice.

In this context, the recently funded “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) project (largely based on such a novel approach) may indeed fill an important gap in the field and provide key insights for counteracting the disabling cascade in the elderly.

N. Sirven, T. Rapp, S. Coretti, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

The “Sarcopenia and Physical fRailty IN older people: multicomponenT Treatment strategies” (SPRINTT) project will provide a unique opportunity to explore health economics issues associated with frailty.